Résultats de la recherche

  • Flux RSS
(1 - 20 of 190)

Pages

MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease?
Atypical forms of optic neuritis.
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Editorial [= Editorial]
Deux nouveaux traitements par voie orale dans la sclérose en plaques rémittente [= Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
Patient perceptions of multiple sclerosis and its treatment.
Current and future treatment approaches for neuromyelitis optica.
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.
Spasticité et vie quotidienne dans la sclérose en plaques [= Spasticity and everyday life in multiple sclerosis]
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Ocrelizumab for the treatment of multiple sclerosis
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Traitement d’induction dans la sclérose en plaques : place du natalizumab [= Natalizumab as induction therapy in multiple sclerosis].
Heroin inhalation-induced unilateral complete hippocampal stroke.
Amours et neurologie [= Love and neurology].
Difficultés ressenties au travail par les patients atteints de sclérose en plaques [= Difficulties experienced at work by patients with multiple sclerosis].

Pages

Islandora displays